Category: Immunological non-responders

  • The IAS HIV Cure & Cancer Forum was held at the renowned cancer research center Institut Curie in Paris on July 22 & 23 of this year. A report from the meeting, authored by Genevieve E. Martin, José Alcami, Jean-Phillipe Spano and Anna Laura Ross, has just been published in the open access Journal of Virus…

  • Research has documented that HIV infection is associated with significantly increased scarring damage to lymphoid tissue, termed fibrosis. Fibrosis can be quantified by measuring the deposition of collagen, and the amount of lymphoid tissue fibrosis in HIV-positive people has been shown to correlate directly with CD4 T cell depletion. A paper published toward the end…

  • In addition to studies covered in prior posts (a possible second pediatric cure case, Sangamo’s gene therapy and limitations of latency-reversing agents), CROI 2014 featured a smorgasbord of presentations related to pathogenesis and cure research. Webcasts of all conference sessions are online, and many posters are now available in PDF format. Brief summaries of some notable studies are…

  • A subset of HIV-positive people who initiate antiretroviral therapy (ART) and achieve suppression of HIV replication experience poor recovery of CD4 T cell numbers. Terms used to describe this subset of individuals include “discordant responders” and “immunological non-responders” (INRs). As yet, there is no universally accepted definition of INRs and a variety of CD4 T…